Amplification of specific chromosomal regions assessed by fluorescent in situ hybridization on Pap smears to be added as screening tool for identifying women at risk of progressing to cervical cancer
Open Access
- 9 October 2017
- journal article
- research article
- Published by IOS Press in Tumor Biology
- Vol. 39 (10)
- https://doi.org/10.1177/1010428317698363
Abstract
Cervical carcinoma is a frequent malignancy in developing countries despite being a preventable disease. For the first time, four screening tests were used simultaneously for identifying women with a risk of developing cervical cancer, to help clinicians and policy makers to implement the best strategy for reducing the burden of this disease. Women visiting a hospital in India were enrolled after institutional ethics clearance and informed consent. Visual inspection using acetic acid and Pap smear tests were performed on 2683 women, and 104 had abnormal cytology: atypical squamous cells of undetermined significance (n = 29), low-grade squamous intraepithelial lesion (n = 41), high-grade squamous intraepithelial lesion (n = 17), and squamous cell carcinoma (n = 17). These and 96 samples, with normal cytology, were subjected to high-risk human papilloma virus testing and fluorescent in situ hybridization evaluation. Women with abnormal cytology were followed for 5 years and evaluated with colposcopy-guided biopsy. Three accepted methods of screening and one novel fluorescent in situ hybridization assay were carried out in 200 cases. Cutoffs for fluorescent in situ hybridization were established. The screening methods had 88%–96% negative predictive value, while positive predictive value was low (20%) for visual inspection using acetic acid, 47% for fluorescent in situ hybridization, 56% for high-risk human papilloma virus, and 73% for combined high-risk human papilloma virus and fluorescent in situ hybridization. Combined high-risk human papilloma virus and fluorescent in situ hybridization had 94% sensitivity, specificity, and negative predictive value, suggesting that simultaneous screening with these two tests is appropriate for identifying women progressing to cervical cancer and not visual inspection using acetic acid, which has low positive predictive value and Pap cytology which requires to be repeated. Policy makers and clinicians can assess feasibility of incorporating this screening strategy to prevent cervical cancer.Keywords
This publication has 17 references indexed in Scilit:
- Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening resultsGynecologic Oncology, 2013
- Comparative study of effectiveness of Pap smear versus visual inspection with acetic acid and visual inspection with Lugol′s iodine for mass screening of premalignant and malignant lesion of cervixIndian Journal of Medical and Paediatric Oncology, 2012
- Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical CancerJNCI Journal of the National Cancer Institute, 2011
- Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) Positivity in Cervical Cancer Screening of Women in a Peri-Urban Area in Andhra Pradesh, IndiaCancer Epidemiology, Biomarkers & Prevention, 2010
- Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinomaBMC Cancer, 2005
- Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, IndiaInternational Journal of Cancer, 2003
- Comprehensive molecular cytogenetic characterization of cervical cancer cell linesGenes, Chromosomes and Cancer, 2003
- Human Papillomavirus and Cervical CancerClinical Microbiology Reviews, 2003
- Immune evasion in human papillomavirus-associated cervical cancerNature Reviews Cancer, 2002
- Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinomaGenes, Chromosomes and Cancer, 1999